MV TELEGRAPH DAILY NEWS
A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug Administration on Tuesday approved Eli Lilly‘s Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The …
Continue reading “FDA approves Eli Lilly Alzheimer’s drug donanemab”
Spectators watch a race on the River Thames at the Henley Royal Regatta in Henley-on-Thames, west of London, on June 30, 2023. Henry Nicholls | Afp | Getty Images LONDON — Harmful E.coli bacteria has been discovered at “alarmingly high” levels in the U.K.’s River Thames just days before elite rowers are due to compete …
Continue reading “Micro organism in Thames forward of rowing Henley Regatta”
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a decision as early as the end of the year. If cleared by the Food and Drug Administration, the company plans to launch Zepbound for so-called obstructive …
Continue reading “Eli Lilly expects FDA name on Zepbound for sleep apnea in close to time period”
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. The injectable weight loss medication Wegovy at New City Halstead Pharmacy in Chicago on April 24, 2024. Scott Olson | Getty Images Good morning! More U.S. employers are covering a buzzy class of medications called GLP-1s for weight …
Continue reading “Extra U.S. employers masking GLP-1s for weight reduction”
Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help physicians provide more accurate treatment for their patients, rose by as much as 15% in its Nasdaq Stock Market debut on Friday, after going public under the ticker symbol “TEM.” Tempus AI priced 11.1 million shares at $37 apiece on …
Continue reading “Google-backed Tempus AI closes first buying and selling day up 9% in Nasdaq debut”
President Joe Biden and former President Donald Trump 2024. Kevin Lamarque | Jay Paul | Reuters Former President Donald Trump on Saturday recognized that the price of insulin is lower under President Joe Biden, but he still wants voters to credit his own administration. “Low INSULIN PRICING was gotten for millions of Americans by me, and …
Continue reading “Trump claims credit score for Biden’s insulin value cap”
Woman sleeping on a plane. Rudi_suardi | E+ | Getty Images A popular pastime on long-haul flights — drinking alcohol before dozing off for a nap — may present health risks even to young and healthy passengers, according to a new study. The combination of alcohol consumption, sleep and the low oxygen concentration at high …
The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the company’s second-ever product to enter the U.S. market. The decision is a win for Moderna, which desperately needs another revenue source amid …
Continue reading “FDA approves Moderna RSV vaccine for seniors”
Dr. Joshua Bederson places Precision Neuroscience’s electrodes onto a brain. Ashley Capoot As the lights dimmed in an operating room at The Mount Sinai Hospital in New York City, Dr. Joshua Bederson prepared to make history. Bederson, system chair for the Department of Neurosurgery at Mount Sinai Health System, is no stranger to long hours …
Continue reading “Neuralink competitor Precision Neuroscience testing human mind implant”
Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multiyear program to reduce costs as it works to rebound from the rapid decline of its Covid business. The announcement is in addition …
Continue reading “Pfizer declares new value slicing program”
